Within the past decade the role of the gut microbiota in metabolic disorders has been extensively investigated (Table 1), and accumulating evidence indicates that a state of bacterial dysbiosis contributes to differences in body weight, insulin sensitivity, glucose metabolism and other cardio-metabolic risk factors among individuals [50], strengthening the gut microbiota as a potential risk factor in the pathogenesis of obesity and its co-morbidities. The gene discussed is INS; the disease is Obesity.